Frank Rimerman Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$760K Sell
10,588
-3,978
-27% -$306K 0.05% 297
2025
Q4
$1.16M Buy
14,566
+4,089
+39% +$322K 0.07% 207
2025
Q3
$790K Sell
10,477
-24
-0.2% -$1.65K 0.05% 265
2025
Q2
$724K Sell
10,501
-2,988
-22% -$196K 0.05% 277
2025
Q1
$914K Buy
13,489
+1,702
+14% +$102K 0.07% 209
2024
Q4
$529K Buy
11,787
+4,571
+63% +$256K 0.04% 296
2024
Q3
$454K Sell
7,216
-2,108
-23% -$123K 0.03% 346
2024
Q2
$551K Buy
9,324
+9,225
+9,318% +$577K 0.04% 320
2024
Q1
$7.9K Hold
99
﹤0.01% 185
2023
Q4
$7.82K Buy
+99
New +$7.05K ﹤0.01% 178

Other funds holding CVS

Frank Rimerman Advisors's CVS Position: Q1 2026 in Review

Frank Rimerman Advisors reduced its CVS Health (CVS) stake by 27% in Q1 2026, selling an estimated $306K and leaving 10,588 shares worth $760K. The position accounts for 0.05% of the portfolio, ranked #297.

Frank Rimerman Advisors first reported a position in CVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.16M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Frank Rimerman Advisors held 10,588 shares of CVS Health worth $760K as of Q1 2026.
  • Frank Rimerman Advisors sold 3,978 CVS Health shares in Q1 2026, an estimated $306K.
  • CVS Health made up 0.05% of Frank Rimerman Advisors's portfolio in Q1 2026, its #297 holding.
  • Frank Rimerman Advisors first reported a position in CVS Health in Q4 2023 and has held it in 10 quarters since.
  • Frank Rimerman Advisors's CVS Health position peaked at $1.16M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.